Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-007064
Filing Date
2024-01-26
Accepted
2024-01-26 11:30:45
Documents
1
Period of Report
2024-01-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm244212-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm244212-2_4seq1.xml 4 4026
  Complete submission text file 0001104659-24-007064.txt   5627
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Issuer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TOURMALINE BIO, INC. 27 WEST 24TH STREET, SUITE 702 NEW YORK NY 10010
Business Address
Thiara Parvinder (Reporting) CIK: 0001995535 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40598 | Film No.: 24565419